Literature DB >> 11124161

Differential alterations in cardiac adrenergic signaling in chronic hypoxia or norepinephrine infusion.

F León-Velarde1, M C Bourin, R Germack, K Mohammadi, B Crozatier, J P Richalet.   

Abstract

Norepinephrine (NE)-induced desensitization of the adrenergic receptor pathway may mimic the effects of hypoxia on cardiac adrenoceptors. The mechanisms involved in this desensitization were evaluated in male Wistar rats kept in a hypobaric chamber (380 Torr) and in rats infused with NE (0.3 mg. kg(-1). h(-1)) for 21 days. Because NE treatment resulted in left ventricular (LV) hypertrophy, whereas hypoxia resulted in right (RV) hypertrophy, the selective hypertrophic response of hypoxia and NE was also evaluated. In hypoxia, alpha(1)-adrenergic receptors (AR) density increased by 35%, only in the LV. In NE, alpha(1)-AR density decreased by 43% in the RV. Both hypoxia and NE decreased beta-AR density. No difference was found in receptor apparent affinity. Stimulated maximal activity of adenylate cyclase decreased in both ventricles with hypoxia (LV, 41%; RV, 36%) but only in LV with NE infusion (42%). The functional activities of G(i) and G(s) proteins in cardiac membranes were assessed by incubation with pertussis toxin (PT) and cholera toxin (CT). PT had an important effect in abolishing the decrease in isoproterenol-induced stimulation of adenylate cyclase in hypoxia; however, pretreatment of the NE ventricle cells with PT failed to restore this stimulation. Although CT attenuates the basal activity of adenylate cyclase in the RV and the isoproterenol-stimulated activity in the LV, pretreatment of NE or hypoxic cardiac membranes with CT has a less clear effect on the adenylate cyclase pathway. The present study has demonstrated that 1) NE does not mimic the effects of hypoxia at the cellular level, i.e., hypoxia has specific effects on cardiac adrenergic signaling, and 2) changes in alpha- and beta-adrenergic pathways are chamber specific and may depend on the type of stimulation (hypoxia or adrenergic).

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11124161     DOI: 10.1152/ajpregu.2001.280.1.R274

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  11 in total

1.  Modelling of alpha1-adrenoceptor-mediated temporal dynamics of inotropic response in rat heart to assess ligand binding and signal transduction parameters.

Authors:  P Sermsappasuk; M Weiss
Journal:  Br J Pharmacol       Date:  2009-02-13       Impact factor: 8.739

2.  Role of the β3-adrenergic receptor subtype in catecholamine-induced myocardial remodeling.

Authors:  Gizem Kayki Mutlu; Ebru Arioglu Inan; Irem Karaomerlioglu; V Melih Altan; Nilgun Yersal; Petek Korkusuz; Marcella Rocchetti; Antonio Zaza
Journal:  Mol Cell Biochem       Date:  2018-01-23       Impact factor: 3.396

3.  Subsequent stress increases gene expression of catecholamine synthetic enzymes in cardiac ventricles of chronic-stressed rats.

Authors:  Ljubica Gavrilovic; Natasa Spasojevic; Sladjana Dronjak
Journal:  Endocrine       Date:  2010-03-25       Impact factor: 3.633

Review 4.  Oxidative stress and oxidant signaling in obstructive sleep apnea and associated cardiovascular diseases.

Authors:  Yuichiro J Suzuki; Vivek Jain; Ah-Mee Park; Regina M Day
Journal:  Free Radic Biol Med       Date:  2006-02-02       Impact factor: 7.376

5.  Novel proteins associated with human dilated cardiomyopathy: selective reduction in α(1A)-adrenergic receptors and increased desensitization proteins.

Authors:  Ting Shi; Christine S Moravec; Dianne M Perez
Journal:  J Recept Signal Transduct Res       Date:  2013-02-06       Impact factor: 2.092

6.  β-Adrenergic signaling, monoamine oxidase A and antioxidant defence in the myocardium of SHR and SHR-mtBN conplastic rat strains: the effect of chronic hypoxia.

Authors:  Klara Hahnova; Iveta Brabcova; Jan Neckar; Romana Weissova; Anna Svatonova; Olga Novakova; Jitka Zurmanova; Martin Kalous; Jan Silhavy; Michal Pravenec; Frantisek Kolar; Jiri Novotny
Journal:  J Physiol Sci       Date:  2017-05-31       Impact factor: 2.781

7.  Chronic intermittent hypoxia affects the cytosolic phospholipase A2α/cyclooxygenase 2 pathway via β2-adrenoceptor-mediated ERK/p38 stimulation.

Authors:  Petra Micova; Klara Hahnova; Marketa Hlavackova; Barbara Elsnicova; Anna Chytilova; Kristyna Holzerova; Jitka Zurmanova; Jan Neckar; Frantisek Kolar; Olga Novakova; Jiri Novotny
Journal:  Mol Cell Biochem       Date:  2016-09-30       Impact factor: 3.396

8.  Modeling the oxygen transport to the myocardium at maximal exercise at high altitude.

Authors:  Jean-Paul Richalet; Eric Hermand
Journal:  Physiol Rep       Date:  2022-04

Review 9.  The autonomic nervous system at high altitude.

Authors:  Roger Hainsworth; Mark J Drinkhill; Maria Rivera-Chira
Journal:  Clin Auton Res       Date:  2007-01-30       Impact factor: 4.435

10.  Adaptations to iron deficiency: cardiac functional responsiveness to norepinephrine, arterial remodeling, and the effect of beta-blockade on cardiac hypertrophy.

Authors:  Lexa Rae Turner; Daniel Aaron Premo; Brett Jason Gibbs; Megan Lesley Hearthway; Madelyne Motsko; Andrea Sappington; LeeAnn Walker; Michael Eugene Mullendore; Herbert George Chew
Journal:  BMC Physiol       Date:  2002-01-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.